Mutations in fukutin related protein (FKRP) are responsible for a common group of muscular dystrophies ranging from adult onset limb girdle muscular dystrophies to severe congenital forms with associated structural brain involvement, including Muscle Eye Brain disease. A common feature of these disorders is the variable reduction in the glycosylation of skeletal muscle a-dystroglycan. In order to gain insight into the pathogenesis and clinical variability, we have generated two lines of mice, the first containing a missense mutation and a neomycin cassette, FKRP-Neo Tyr307Asn and the second containing the FKRP Tyr307Asn mutation alone. We have previously associated this missense mutation with a severe muscle-eye-brain phenotype in several families. Homozygote Fkrp-Neo Tyr307Asn mice die soon after birth and show a reduction in the laminin-binding epitope of a-dystroglycan in muscle, eye and brain, and have reduced levels of FKRP transcript. Homozygous Fkrp Tyr307Asn mice showed no discernible phenotype up to 6 months of age, contrary to the severe clinical course observed in patients with the same mutation. These results suggest the generation of a mouse model for FKRP related muscular dystrophy requires a knock-down rather than a knock-in strategy in order to give rise to a disease phenotype.
Introduction
The congenital muscular dystrophies (CMD) are a genetically heterogeneous group of autosomal recessive disorders, presenting in infancy with muscle weakness, contractures and dystrophic changes on skeletal muscle biopsy (Muntoni and Voit, 2004) . A number of forms are now known to be associated with mutations in genes [POMT1, POMT2, POMGnt1, LARGE, fukutin and fukutin related protein (FKRP)] encoding for proteins that are either putative or determined glycosyltransferases lending support to the idea that the aberrant post-translational modification of proteins may represent a new mechanism of pathogenesis in the muscular dystrophies (Michele and Campbell, 2003; Barresi and Campbell, 2006) . One characteristic of the muscle of patients with mutations in these six putative glycosyltransferase genes is a marked hypoglycosylation of a-dystroglycan Brockington et al., 2005; van Reeuwijk et al., 2005) which has led to the suggestion of dystroglycanopathies as a general term to describe these conditions. a-Dystroglycan is a central component of the dystrophin associated complex and is expressed in a number of different tissues including the brain. Its abnormal glycosylation affects its interaction with members of the extracellular matrix, including laminin, perlecan, neurexin and agrin within the basement membrane. This reduction in ligand binding within the basement membrane is thought to underlie both the muscular dystrophy but also the structural brain defects including cobblestone lissencephaly (Michele et al., , 2003 .
Mutations in POMT1 (Beltran-Valero et al., 2002) , POMT2 (van Reeuwijk et al., 2005) , POMGnT1 (Yoshida et al., 2001) , LARGE (Longman et al., 2003; van Reeuwijk et al., 2007) and Fukutin (Toda, 1999) are typically associated with severe muscular dystrophy and structural brain defects, ranging from the fatal Walker Warburg syndrome (WWS) to variants such as Muscle Eye Brain disease (MEB) and Fukuyama CMD (FCMD). We originally identified mutations in the gene encoding for FKRP, and showed them to be responsible for a variant of CMD (MDC1C) and for a common form of relatively mild limb girdle muscular dystrophy (LGMD2I) (Brockington et al., 2001a, b) , two conditions without any brain involvement. However, mutations in FKRP have recently been identified in patients with severe structural eye and brain involvement resembling WWS and MEB disease (Beltran-Valero et al., 2004) . More recently, we and others were able to significantly expand the phenotypic spectrum associated with mutations in POMT1, POMT2, fukutin and POMGnT1, to include patients with minimal or no evidence of central nervous system involvement and with a LGMD phenotype (Balci et al., 2005; Godfrey et al., 2007; Yanagisawa et al., 2007; Clement et al., 2008) . This lends support to the hypothesis that the phenotype of patients belonging to this group of disorders depends not so much on the specific gene primarily affected (i.e. POMT1, POMT2, POMGnT1, LARGE, FKRP or fukutin) but rather the severity of the specific mutation and presumably its effect on the structure and thus the function of the gene product (Godfrey et al., 2007) .
In order to better understand the functional consequences of an alteration in FKRP activity, we have now generated two lines of mice: the first containing a point mutation FKRP Tyr307Asn and the second containing this missense mutation and a neomycin cassette, . This mutation in the homozygous state has previously been associated with MEB in two separate families (Beltran-Valero et al., 2004; Mercuri et al., 2006) , and more recently in other families of Swedish descent (J. Vissing, personal communication) and was also identified at the heterozygous state in combination with the Leu276Ile in a patient with severe LGMD2I (Sveen et al., 2006) , suggesting it behaves as a 'severe' FKRP mutation in humans. Surprisingly, however, mice homozygous for this mutation shows no discernable phenotype strongly suggesting that the insertion of missense mutations into the mouse Fkrp gene may not perturb FKRP function as is the case for human patients. However, mice with the mutation which retain the neomycin selection cassette in intron 2 show a marked depletion in FKRP transcript levels and died at or soon after birth with a phenotype resembling MEB. The phenotype of these mice demonstrate a role for FKRP activity in muscle, eye and brain and suggests that a reduction in the amount of functionally active FKRP may represent a mechanism of disease in FKRP related disorders. 
Material and methods

Southern blot analysis
Genomic DNA was extracted from G418-resistant ES cell clones. To determine whether homologous recombination had occurred we PCR amplified a 1000 bp probe which anneals to the endogenous Fkrp mouse sequence 5 0 to the DNA sequences contained within the original targeting vector (Fig. 1) . DNA derived from each potentially positive clone was digested with the restriction enzyme HindIII. When homologous recombination has occurred, the probe identifies a 5-kb band instead of 6.7-kb band as is the case for the endogenous mouse sequence. The difference in size is due to an additional HindIII site present in the targeting vector.
Generating and genotyping of mice
One homologous recombinant ES clone was microinjected into blastocysts from 129J mice. The resulting male chimeras were then bred with female C57BL6 mice to generate germ line-transmitted heterozygous mice. These mice were then crossed to generate mice homozygous for the mutation and also the 'neomycin' cassette FKRP-Neo Tyr307Asn+/+ . In order to remove the neomycin cassette heterozygotes were crossed with b-actin Cre transgenic mice (Lewandoski et al., 1997) to create mice homozygous for Fkrp Tyr307Asn . In order to further test the pathogenesis of the missense mutation, we also crossed FKRP Tyr307Asn+/+ mice with FKRP Tyr307AsnNeo+/À mice to obtain FKRP Tyr307Asn+/+/Neo+/À mice.
Statistical analysis was performed using Graftpad TM (Prism) software.
Offspring from these crosses were genotyped by PCR analysis using mouse tail/ear DNA. gDNA was prepared from ear clips used for identification, the tissue were digested in Direct PCR Lysis (Ear) (Eurogentec) containing proteinase K (0.2 mg/ml) at 55 C overnight.
PCRs were performed with 3 ml gDNA template using G-C rich template PCR kit (Roche diagnostics). Genotyping of affected newborns together with controls was performed on gDNA prepared from tail tissue. Tails ($0.50 cm) were digested in 500 ml of SNET buffer (1% SDS/400 mM NaCl/5 mM EDTA/20 mM Tris-HCl, pH 8.0) containing proteinase K (0.2 mg/ml) at 55 C overnight. After extraction with phenol/chloroform and isopropanol precipitation, samples were washed with 70% ethanol and resuspended in 200 ml ddH 2 O. The gDNA used as a template for PCR using G-C rich template PCR kit (Roche diagnostics). Genotyping was performed by PCR and sequencing of the Fkrp gene was used to confirm the point mutation (c.919 T 4 A). The following PCR primers used to amplify either the Neomycin cassette (NeoRPF2:TTCTCCTCTTCCTCATCTCC; NeoRPR2:CCAAGCT CTTCAGCAATTATC) or the Fkrp gene (LA1F:CCGAGTTTG TGGCTCTAGT; LA1R: TAGATGGCCCAGATCTACGTC), respectively, and sequencing was performed in both directions using primers LA1R and LA2F (GTCTGGTGAGCTGGGAAG) on a 3730XL DNA Analyser (Applied Biosystems) at the MRC DNA Core laboratory. Homozygous wild-type, homozygous Tyr307Asn missense mutants or heterozygous mice were clearly identified using the Vector NTi advance10 software (Invitrogen).
RT-PCR analysis
Tissues of interest were dissected out and homogenized with liquid nitrogen using a mortar and pestle and the lysate passed through a QiaShredder Õ (Qiagen). The RNA was isolated from the homogenized tissue using an RNeasy Õ kit (Qiagen) and eluted into 30 ml. About 1 mg of RNA was reverse transcribed with Superscript Õ III for qRT-PCR kit (Invitrogen). qRT-PCR was performed on a 7500 FAST Real-Time PCR system (Applied Biosystems) using a FAM (tm) reporter dye system for each reaction 0.8 ml of cDNA was used as template in a PCR mix consisting of 1 ml of primer mix, 10 ml TaqMan Universal PCR Mastermix (Applied Biosystems) and 8.2 ml H 2 O. The primers for the gene expression assays were sourced commercially from Applied Biosystems: Mm00557870_mL (FKRP) and Mm99999915_gL (GAPDH) which served as an endogenous control. All reactions were performed in triplicate.
Immunohistochemistry
Muscle and brain samples were frozen in isopentane cooled in liquid nitrogen. Cryostat sections were incubated with antibodies to a-dystroglycan (IIH6, Upstate Biotechnology), collagen XVIII (gift from J. Couchman), GT-20, core peptide to a-dystroglycan (goat polyclonal, a gift from K. Campbell), RC2 (Developmental Studies Hybridoma Bank), NeuN (Chemicon), Ctip2 (Abcam), laminin a2 (Alexis), b1 (Chemicon), g1 (Chemicon), MHCd (Novocastra) and P6 (Sherratt et al., 1992) . All primary antibodies were followed by biotinylated anti-rat/rabbit/mouse as appropriate and streptavidinAlexa 488 or 594 (Molecular Probes) for 30 min. Nuclei were stained with Hoechst 33342 (Sigma). All dilutions and washings were made in phosphate buffered saline. Sections were mounted in aqueous mountant and viewed with epifluorescence using a Leica Diaphot microscope equipped with Leica HCX PL Fluotar objectives at Â10 (numerical aperture 0.3), Â20 (numerical aperture 0.4) and Â40 (numerical aperture 0.75). Images were digitally captured with CoolSnap HQ TM (Photometrics) CCD monochrome camera using a Metamorph 7 Õ (Universal Imaging Inc.) imaging system. All images were compiled using Photoshop CS (Adobe). Where direct comparisons have been made fluorescent images were captured with equal exposure and have had equal scaling applied.
SDS-PAGE and western blotting
Muscle proteins were extracted in sample buffer consisting of 75 mM Tris-HCl, 1% SDS, 2-mercaptoethanol, plus a cocktail of protease inhibitors (antipain, aprotinin and leupeptin). Soluble proteins were resolved using a NuPage TM Pre-cast gel (4-12% Bis-Tris; Invitrogen) and then transferred electrophoretically to nitrocellulose membrane (Hybond-ECL, Amersham). Nitrocellulose strips were blocked in 10% BSA (Jackson) in KC buffer [20 mM Tris, 100 mM NaCl] with IIH6 (upstate) antibody overnight at 4 C. After washing they were incubated with HRP-anti-mouse IgM (Jackson) for 1 h at room temperature. Membranes were visualized using chemiluminescence (ECL+Plus, Amersham). Laminin overlay was performed as described previously . Fig. 1 Targeting strategy. The right hand arm of the construct was 3.5 kb in length and consisted of the coding region exon 3, flanked by intronic sequences and the 3 0 -UTR, respectively. The left hand arm consisted of $3 kb of intronic sequences amplified from Fkrp intron 2. Site-directed mutagenesis was used to introduce Tyr307Asn into the right hand arm. The floxed neomycin cassette acted as a positive selection marker and was placed within the region of Fkrp homology. A negative selection marker consisting of a Herpes simplex thymidine kinase (HSVtk) was inserted in the construct outside the region of Fkrp homology. Probes were generated for Southern blotting to identify targeted ES cell clones. To determine whether homologous recombination had occurred we PCR amplified a 1000-bp probe which anneals to the endogenous Fkrp mouse sequence 5 0 to the DNA sequences contained within our targeting vector. DNA derived from each potentially positive clone was digested with the restriction enzyme HindIII. When homologous recombination has occurred, the probe identifies a 5-kb band instead of 6.7-kb band as is the case for the endogenous mouse sequence. The difference in size is due to an additional HindIII site present in the targeting vector.
Distribution of nuclei in the cortex
Three transverse sections selected from each of three Fkrp-Neo Tyr307Asn mice and three control littermates were analysed at birth. The distance from the ventricular zone to the pial basement membrane was divided into six equal regions. The number of nuclei was then counted within each layer and expressed as a percentage of the total number of nuclei across all layers.
Results
Generation of FKRP-Neo
Tyr307Asn and FKRP Tyr307Asn +/+ mice
We generated and analysed two lines of mice, one with a knockin mutation FKRP Tyr307Asn+/+ previously associated with a MEB-like condition in two homozygous patients, and the other FKRPNeo Tyr307Asn which contained in addition to the knock-in mutation, a Neo cassette in intron 2. In both lines the number of homozygote mice born was $25%, consistent with there being no embryonic lethality. Details of the targeting strategy are shown in Fig 
FKRP Tyr307Asn+/+ mice are phenotypically normal
Body weights of FKRP Tyr307Asn+/+ mice (9.4 AE 0.4 n = 6 female and 9.4 AE 0.3 n = 4 male) at 6 weeks of age were not significantly different from wild-type controls (9.0 AE 0.3 n = 8 female and 10.3 AE 0.6 n = 5 male). Muscle histology of the lower hindlimb at 4 weeks of age was indistinguishable from controls, as was immunolabelling for IIH6, an antibody directed against the laminin binding epitope of glycosylated a-dystroglycan ( Fig. 2 ) and laminin a2 (data not shown), the former of which is severely deficient in dystroglycanopathy patients. Haematoxylin and eosin staining of frozen sections of eyes removed from FKRP Tyr307Asn+/+ mice showed the presence of a normal retina, retinal pigmented epithelium, lens, optic nerve, cornea and ciliary margin in both FKRP Tyr307Asn+/+ and control littermates.
Gross anatomy of the brain and heart was also indistinguishable from controls. To date these mice show no overt clinical phenotype and display normal feeding and exploratory behaviour up to 6 months of age. To further test the effect of the missense mutation we also crossed FKRP Tyr307Asn+/+ mice with FKRP Tyr307AsnNeo+/À
. The resulting FKRP Tyr307Asn+/+/Neo+/À mice were within the normal body weight range at birth and were viable. Further analyses of the brain histology of these mice showed them to be indistinguishable from normal littermate controls.
A reduction in Fkrp transcript levels is associated with perinatal lethality
Mice homozygous for FKRP-Neo Tyr307Asn die at or soon after birth. Some mice died prior to feeding whereas others moved, breathed independently and suckled. There was no evidence of either kyphoscoliosis, joint contractures or microcephaly and their external anatomy was comparable with that of control or heterozygote littermates (Fig. 3A) . Haematoxylin and eosin stained transverse sections of the body indicated well-preserved intercostal, paraspinal and diaphragm muscles. Tongue and cranial muscles were also apparently normal (data not shown). Body weight at birth was, on average, approximately one-third less than that of their littermates (Table 1 , P = 0.0001). Quantitative real time PCR (qRT-PCR) of Fkrp in these mice indicated that FKRP-Neo Tyr307Asn homozygotes expressed only $40% of the levels of Fkrp mRNA present in wild-type controls (Fig. 3B) . Western blotting showed a reduction in the band identified by IIH6 in brain, skeletal muscle and heart of the FKRP-Neo Tyr307Asn homozygotes relative to wild-type littermates (Fig. 3C) . A laminin overlay confirmed that this was associated with a reduction in laminin binding in the mutant relative to control skeletal muscle and brain (Fig. 3D ).
FKRP-Neo
Tyr307Asn mice display a reduced muscle mass and hypoglycosylation of a-dystroglycan At the time of birth both fore and hindlimb muscles of the FKRPNeo Tyr307Asn showed a reduction in fibre density relative to their normal and heterozygote littermates irrespective of whether the animals were found dead or were euthanized (Fig. 4A ). There was no evidence of fibre necrosis or regeneration although there was a significant increase in the percentage of fibres with central nuclei in the tibialis anterior (TA) and extensor digitorum longus (EDL) in the mutant homozygotes relative to controls (Table 1) . Gomori Trichrome staining showed that the apparent space in between the fibres was due to oedema rather than excess connective tissue (Fig. 4A) . NADH staining and immunolabelling for developmental myosin (MHC-d) showed a similar level of fibre type differentiation in FKRP-Neo Tyr307Asn and control mice (data not shown).
Immunolabelling for IIH6 and laminin a2 was reduced in all muscles of the FKRP-Neo Tyr307Asn homozygote mice relative to wild-type controls (Fig. 4A) . With respect to laminin a2 this reduction varied depending on the individual muscle. The level of immunolabelling for laminin b1 (data not shown) and g1 were similar in both mutant and controls suggesting that another laminin a chain might compensate for the absence of laminin a2. This has previously been demonstrated in primary laminin a2 deficiency (Sewry et al., 1995) . Perlecan immunolabelling was also indistinguishable between FKRP-Neo Tyr307Asn and wild-type muscle indicating that the deposition of this protein may be less dependent on a-dystroglycan glycosylation than laminin a2. Collagen IV immunolabelling was used as a general marker for the basement membrane preservation and showed no discernable differences between FKRP-Neo Tyr307Asn homozygotes and controls (data not shown). Previous reports suggest that in patients some FKRP mutations are associated with a disruption of components of the dystrophin associated protein complex (DAPC) (MacLeod et al., 2007) we therefore also immunostained for dystrophin but found no significant difference between FKRP-Neo Tyr307Asn mice and control littermates (data not shown).
The inner limiting membrane of the eye is perturbed in FKRP-Neo Tyr307Asn mice
Whilst the eyes of the FKRP-Neo Tyr307Asn homozygote mice were often smaller, this appeared to be a reflection of the reduction in overall body size rather than a disproportionate reduction in the size of the eye. Retinal folding in frozen sections of the eye is known to be a common artefact, however, this change was marginally more pronounced in eyes from the FKRP-Neo Tyr307Asn homozygote mice. The most striking difference between FKRP-Neo Tyr307Asn homozygote and wild-type eyes was the presence of ectopic nuclei, outside the inner limiting membrane (ILM), within the vitreous body of the mutant but not controls (Fig. 5) .
Immunostaining for laminin g1 and perlecan (markers of the basement membrane) clearly indicate that the ILM is disrupted in the FKRPNeo Tyr307Asn eye, although it was present in the vasculature ( Fig. 5H and N, respectively) . Both these markers were present in the eyes of age-matched controls ( Fig. 5G and M, respectively) .
Immunostaining for laminin a1, b1 collagen IV and collagen XVIII further support these observations (data not shown). Interestingly no staining was detected for laminin a2 in either the FKRPNeo Tyr307Asn or controls (data not shown) and similarly, only punctate IIH6 immunostaining was evident in control retinas that was absent in FKRP-Neo Tyr307Asn homozygotes. These data contrast with immunostaining with GT-20 (an antibody to the core protein of a-dystroglycan) that clearly showed the presence of a-dystroglycan in the ILM of controls and a reduction in FKRP-Neo Tyr307Asn homozygotes indicating that in specific locations such as the eye. FKRP levels facilitate a-dystroglycan binding to a laminin chain other than a2. This interaction appears to be independent of the IIH6 epitope and is disrupted when FKRP levels are reduced. Antibodies to perlecan, collagens IV and XVIII also identify the ILM associated vasculature which appeared not to be significantly different between FKRP-Neo Tyr307Asn homozygotes and controls (data not shown).
Alterations in the pial basement membrane of FKRP-Neo Tyr307Asn are associated with a marked disturbance in neuronal migration
Coronal sections of the brain of FKRP-Neo Tyr307Asn mice stained with haematoxylin and eosin showed a clear disruption of the neuronal layering of the cerebral cortex and partial fusion of the intrahemispheric fissue (Fig. 6A-D) . Immunolabelling showed a marked reduction in both IIH6 (Fig. 6A , E and F) and laminin a2 (Fig. 6A , G and H) at the pial basement membrane, whilst the distribution of laminin g1 (Fig. 6A , K and L), perlecan (Fig. 6A , I and J) and collagen IV (data not shown) was highly disorganized and more diffuse compared with controls. The degree to which this basement membrane was disorganized varied between individual mutants. Radial migration is generally guided by the radial glia cells (identified using the RC2 antibody) which form the scaffold along which neurons migrate. RC2 staining indicated that the radial glia cell population in the FKRP-Neo 3) . A reduced laminin binding affinity is observed in both the skeletal muscle and brain of the FKRP-Neo Tyr307Asn mice.
was highly disorganized and the radial glial endfeet fail to from a glial limitans at the pial surface thus resulting in a disruption of the glial scaffold (Fig. 6A, I and J). There was also a marked alteration in the density and distribution of nuclei at different levels throughout the cortex, and a reduction in the total number of nuclei (Fig. 6B) . Nuclei counts performed on haematoxylin and eosin stained sections illustrated that there were $48% fewer nuclei present in the region of the cortex closest to pia surface in the FKRPNeo Tyr307Asn relative to age-matched controls (Fig. 6B: A-C).
Immunolabelling with the neuronal marker NeuN, which identifies a population of post mitotic neurons confirmed that many of these misplaced nuclei were of neuronal origin ( Patients with FKRP mutations and brain involvement show evidence of alterations in cerebellar development and work in Large myd mice shows that the tangential migration of a subgroup of hindbrain neurons may be disrupted (Qu et al., 2006) . In the mouse, granule cells originate from the rhombic lip at around E13-14, subsequently undergo an inward radial migration along Bergmann glia fibres to the internal granular layer, which peaks between P5 and P13. A role for a-dystroglycan in this process is strongly suggested by the phenotype of the Large myd mouse where significant numbers of granule neurons are delayed in their migration due to either a physical disruption of the glial scaffolding and/or altered neuronal-glial guide interactions (Qu et al., 2006) . Whilst a large part of cerebellar development takes place postnatally in the mouse we were nonetheless able to examine the basement membrane. At P0 the labelling with either IIH6 or GT-20 in control mice, was present at only very low levels but was completely absent in FKRP-Neo
Tyr307Asn
. Laminin a2, g1 and perlecan labelling was more diffuse in the FKRP-Neo Tyr307Asn relative to controls confirming that as with the pial-glial limitans this basement membrane is markedly disrupted in the FKRP-Neo Tyr307Asn mice.
The consequences of this on the external granule layer were not apparent at this stage although immunolabelling for RC2, which identifies the Bergmann glia, showed some disorganization in the mutant relative to controls (data not shown).
Discussion
In order to investigate the role of FKRP we have now generated and analysed two lines of mice, the first of which carries a Fkrp knock-in mutation (Fkrp c.919T4A
) that results in a Tyr307Asn missense mutation and the second which carries both the Tyr307Asn mutation and a neomycin cassette in intron 2. The homozygous inheritance of the Tyr307Asn mutation is associated with a severe MEB phenotype in the human (Beltran-Valero et al., 2004; Mercuri et al., 2006) . However, mice homozygous for this mutation have no apparent phenotype suggesting that this mutation alters FKRP function in the human but not the mouse despite the high level of sequence homology (94%) between these two species (NP_077277.1) (NP_775606.1) (www.epasy.org/tools/sim-prot.html). Despite these findings, FKRP is clearly necessary for the mouse as a reduction in the level of expression induced by inclusion of a neomycin cassette in intron 2 clearly results in a severe phenotype. This suggests that the introduction of other missense mutations into the mouse Fkrp gene may not give rise to a phenotype. Whilst surprising these findings are not without precedent; mice carrying a Arg142Cys Notch 3 knock-in mutation do not develop a CADASIL-like phenotype despite the fact that human and mouse Notch 3 proteins display 91% identity at the primary structural level (Lundkvist et al., 2005) . Similarly the introduction of a missense mutation in the a-sarcoglycan gene, which in human patients is associated immunostained with GT20 (dystroglycan core) (A and B), Laminin a2 (C and D), Laminin g1 (E and F) and perlecan (G and H) antibodies. A reduction in the staining was observed in each case. Scale bars are 25 mm (A and B) or 50 mm (C-H).
with a muscular dystrophy, fails to give rise to this phenotype when introduced into the mouse genome strongly suggesting the existence of important species specific quality control processes (Kobuke et al., 2008) and the effect of the mutation on protein folding in the two species. FKRP-Neo Tyr307Asn homozygote mice display a muscle eye brain phenotype and a quantitative reduction in Fkrp expression which in homozygotes is $40% of the levels observed in normal control littermates. Since mice homozygous for the Tyr307Asn mutation have Fkrp transcript levels comparable with controls and do not display a disease phenotype, these observations strongly suggest that this reduction is playing the pathogenic role. The generation of a hypomorph allele due to the intronic inclusion of a neomycin resistance cassette has previously been reported for other genes such as Fgf8 and N-myc and has proved to be particularly useful when a null is embryonic lethal (Meyers et al., 1998; Nagy et al., 1998) . Indeed homozygosity for Fkrp null alleles has never been observed in the human and since a 60% reduction of Fkrp transcript levels is lethal in the perinatal period, it would seem likely that a total absence of Fkrp is embryonic lethal in both species. This observation is of particular significance since it indirectly suggests that the generation of a knock-out for Fkrp might not be a useful strategy and that the phenotype induced by other 'milder' missense mutations such as the Leu276Ile might not produce any discernable phenotype in this species.
We noted a reduction in muscle mass in both fore and hindlimb muscles of the FKRP-Neo Tyr307Asn mice relative to controls but no evidence of necrosis or fibrosis, which is similar to previous reports in the POMGnT1 null mice which were evaluated up to 2 days after birth (Liu et al., 2006) . However, unlike the FKRPNeo Tyr307Asn homozygotes their lifespan is variable and the muscle of those which survive to adulthood displays a marked variability in fibre size and an increase in the incidence of central myonuclei (Liu et al., 2006) . LARGE myd mice are also smaller at birth than their littermates (J. Hewitt, personal communication) and display an age-dependent progressive muscle pathology characterized by necrosis and regeneration, central nuclei and proliferation of endomysial connective and fatty tissue although there is no data on the morphology of their muscle at birth (Holzfeind et al., 2002) . On the basis of our findings and those reported for the POMGnT1 mouse it would seem that the dystrophic phenotype develops after birth which is similar to dystrophin deficient mdx mice which show no morphological abnormalities at birth but go on to develop a dystrophic phenotype at 4-6 weeks of age. Nonetheless these observations suggest that an early reduction in muscle mass may be a significant component of the disease in dystroglycanopathy patients. Indeed in the tibialis anterior and extensor digitorum longus there was a reduction in fibre size and number suggesting that myoblast proliferation and/or fusion has been perturbed. Interestingly a recent in vitro study of satellite cells derived from a POMGnT1 null mouse was shown to display a defect in satellite cell proliferation but not fusion (Miyagoe-Suzuki et al., 2007) . A role for dystroglycan in satellite cell function has also previously been suggested by the relatively mild phenotype and efficient muscle regeneration of mice with a skeletal muscle fibre specific loss of dystroglycan (MCK-DG-null) which retain dystroglycan expression in the satellite cell population Cohn, 2005) . However, the relevance of these latter observations to our own remains to be proven particularly since the MCK-DG-null mice are devoid of dystroglycan (both a and b) rather than the laminin binding epitope of a-dystroglycan as in our model.
There was a marked reduction in immunolabelling for IIH6 and laminin a2 in the FKRP-Neo Tyr307Asn mice relative to controls, which demonstrates a muscle phenotype in these mice at postnatal day 0 despite the absence of any obvious dystrophic process. This reduction in IIH6 and laminin a2 is similar to skeletal muscle biopsies from patients with FKRP mutations, the absence of dystrophy in our model is most likely due to their early developmental stage. WWS and MEB are both associated with cobblestone (type II) lissencephaly (Dobyns et al., 1989 )-the pathological correlate of which is neuronal over-migration during neocortex lamination secondary to defects in the formation or maintenance of the pial glial limitans (Yamamoto et al., 2004) . Our finding that a reduction in IIH6 immunolabelling at the pial basement membrane of the FKRP-Neo
Tyr307Asn mice was associated with the presence of cells protruding into the sub-arachnoid space and a more diffuse labelling with other basement membrane markers such as laminin g1 and perlecan clearly show that the proper glycosylation of a-dystroglycan is essential for maintaining the integrity of the pial basement membrane. In the absence of an intact basement membrane at the pial surface the endfeet of the radial glia fail to form the glial limitans, which is necessary to anchor the radial glia scaffold. A similar finding has been reported by Halfter in the retina where the Mü llar glia irreversibly retract after disruption of the ILM resulting in apoptosis of the retinal ganglion cells (Halfter et al., 2005) . In our model the result of the disrupted radial scaffold is a mislocalization of the neurons, in particular the later migrating neurons, within the cerebral cortex. Our model bears many similarities with others including those with a targeted deletion of brain dystroglycan , integrin b1 (Graus-Porta et al., 2001) and the nidogen binding site of laminin g1 (Halfter et al., 2002) all of which, in common with our model, show a disruption in the glial scaffold as a secondary consequence of defects in the pial-glial limitans. Interestingly, the fukutin chimeras were reported to show only localized disorganization of glia contrary to the widespread disruption that we observed in our mice. Whilst these differences might relate to the presence of normal cells in fukutin chimeras, more recent work in the cerebellar cortex of the POMGnT1 null mouse has noted that alterations in the Bergmann glial scaffold were prominent where there were localized breaches in the pial basement membrane (Li et al., 2008) . Our observations, therefore, imply that in the FKRP-Neo Tyr307Asn mouse there is a more widespread disturbance of the basement membrane rather than the localized disruption observed in the other models. MRI studies of patients with FKRP mutations illustrate both the heterogeneity in the spectrum of brain changes but also a hierarchy of severity, with the cerebellum appearing to be the most vulnerable structure (Mercuri et al., 2006) . The Large myd mutation is known to affect tangentially migrating neurons just beneath the pial surface (Qu et al., 2006) . Whilst we observed no irregularities in the external granule cell layer we did note a marked disruption in the RC2 labelled cells and a significant alteration in the continuity of the cerebellar basement membrane as indicated by laminin a2, g1 and perlecan immunolabelling. We detected only very low levels of a-dystroglycan using either GT-20 or IIH6 in control cerebellum labelling which was absent in the FKRP-Neo Tyr307Asn mice. This suggests, as was seen with the ILM of the eye, that epitopes other than IIH6 mediate binding to the extracellular matrix in this part of the brain. The finding that RC2 labelling was disturbed demonstrates the functional relevance of these findings to further cerebellar development (Fig. 7) . Eye abnormalities are associated with the more severely affected secondary dystroglycanopathy disorders such as WWS and MEB where patients have displayed cataract and opacity of the crystalline lens and other posterior chamber defects. The ILM is a basement membrane which effectively separates the retina from the vitreous body (Candiello et al., 2007) and contains proteins such as perlecan, collagen IV, laminin-1, nidogen, agrin and collagen XVIII. Its mechanical strength together with that of the basement membranes of the ocular vasculature are known to be essential for normal eye development (Halfter et al., 2005; Candiello et al., 2007) . Enzymatic disruption of the ILM in the chick retina has been shown to induce irreversible reaction of the glial endfeet (Halfter et al., 2005) . We observed a marked disorganization of the ILM in the newborn FKRP-Neo Tyr307Asn mice which was associated with an invasion of cells into the vitreous. Interestingly, whilst dystroglycan was present in the ILM of controls as detected with the antibody (GT20) this basement membrane did not label with IIH6. The goat polyclonal GT-20 was raised against the entire dystroglycan glycoprotein complex and purified against a hypoglycosylated full-length a-dystroglycan human fusion protein expressed in HEK-293 cells. This antibody recognizes a form of a-dystroglycan that migrates as a 120 kDa band on Western blot . As reported by others, laminin a2 is not present in the ILM. Several different dystroglycan isoforms have previously been reported in the adult rat eye, including that identified by IIH6 which contrasts with the observed absence of IIH6 staining in the FKRP-Neo Tyr307Asn neonatal retina (Moukhles et al., 2000) . The observations presented in this article focus on the neonatal mouse eye and it is unclear at this juncture whether the presence or absence of the IIH6 epitope at the ILM is a developmental, species or strain specific difference. Our observations are therefore particularly relevant since they show for the first time that a disruption of the basement membrane in these mice may be caused by the absence of an epitope distinct from that identified by IIH6, and a ligand other than laminin a2.
Fukutin chimera mice show various eye anomalies such as lens opacification, disorganization of the retinal laminar and also retinal detachment and misfolding (Takeda et al., 2003) . The POMGnT1 null mice and the Large myd mice also have an eye phenotype including thinner inner and outer neuroblastic layers (Liu et al., 2006) . Despite the disruption in the ILM in FKRP-Neo Tyr307Asn mice, we noted no marked alteration in the thickness of the neuroblastic layers suggesting that such changes are most likely manifested during postnatal growth of the retina.
In conclusion, we have demonstrated that it is a reduction in Fkrp transcript levels that give rise to structural eye, brain and muscle abnormalities rather than the presence of missense mutations-at least with respect to the mutation (Fkrp Tyr307Asn ) that we have introduced. Given that our mutation gives rise to a severe muscle eye brain disease in the homozygous condition it seems highly likely that other missense mutations associated with milder phenotypes will also fail to give rise to a phenotype in the mouse. In summary, this mouse represents a unique model in which to investigate future therapeutic options in the dystroglycanopathies.
